Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3558
Gene Symbol: IL2
IL2 		0.300 Therapeutic group CTD_human Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma. 15577323 2004
Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1 		0.300 Therapeutic group CTD_human Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma. 15577323 2004
Entrez Id: 6778
Gene Symbol: STAT6
STAT6 		0.100 Biomarker group HPO
Entrez Id: 9702
Gene Symbol: CEP57
CEP57 		0.100 Biomarker group HPO
Entrez Id: 4665
Gene Symbol: NAB2
NAB2 		0.100 Biomarker group HPO
Entrez Id: 9184
Gene Symbol: BUB3
BUB3 		0.100 Biomarker group HPO
Entrez Id: 699
Gene Symbol: BUB1
BUB1 		0.100 Biomarker group HPO
Entrez Id: 701
Gene Symbol: BUB1B
BUB1B 		0.100 Biomarker group HPO
Entrez Id: 2271
Gene Symbol: FH
FH 		0.100 Biomarker group HPO
Entrez Id: 9319
Gene Symbol: TRIP13
TRIP13 		0.100 Biomarker group HPO
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10 		0.010 Biomarker group BEFREE All 3 neoplasms were diffusely positive with p16 (block-type immunoreactivity) and the anal canal lesion contained high-risk human papillomavirus type 16; the 2 vaginal neoplasms underwent human papillomavirus testing but were unsuitable for analysis. 29257037 2019
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.010 Biomarker group BEFREE All 3 neoplasms were diffusely positive with p16 (block-type immunoreactivity) and the anal canal lesion contained high-risk human papillomavirus type 16; the 2 vaginal neoplasms underwent human papillomavirus testing but were unsuitable for analysis. 29257037 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.010 Biomarker group BEFREE An F-FDG PET/CT was performed to exclude its metastatic possibility, which showed the vaginal tumor was the only lesion with F-FDG avidity. 30688732 2019